Parmax Pharma Limited announced that based on the recommendation of Nomination and Remuneration Committee and subject To Approve the shareholders of the Company, the Board of Directors of the Company at their meeting held on April 25, 2023 has appointed Mr. Nikhil Uchat (DIN: 08427983) as an Additional Independent Director of the Company for a period of 5 (five) years effective from April 25, 2023 subject to the approval of the shareholder. Mr. Nikhil Uchat (49) is Commerce graduate and is having vast experience in the field of Trading, Manufacturing and finance. Mr. Nikhil Uchat (DIN: 08427983) is not related to any of the Directors on the Board.

Mr. Pramay Amritlal Chhatra (DIN 07437291) has tendered his resignation as Independent Director and from the Directorship of the Company that will take effect from the close of business on April 25, 2023. The Board of Directors of the Company took note of the resignation of Mr. Pramay Amritlal Chhatra at its Meeting held on today.